Latest TGen Drug Development Services Stories
TGen and VARI study cancer in dogs to find new treatments for humans.
Apthera, Inc., a Scottsdale, Arizona-based biotechnology company focused on cancer immunotherapy, today announced an alliance with TGen Drug Development Services (TD2) under a Master Services Agreement.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.